-+ 0.00%
-+ 0.00%
-+ 0.00%

Evaxion Biotech Q3 EPS $(0.01), Inline

Benzinga·11/19/2026 12:04:07
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 200 percent decrease over earnings of $0.01 per share from the same period last year.